Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eteplirsen
eteplirsen
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Sarepta's Pathway To Approval
Seeking Alpha
Fri, 06/24/16 - 09:30 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA
3 Biotechs That Just Announced Successful Phase 2 Trials
24/7 Wall St
Sun, 06/12/16 - 10:03 pm
clinical trials
TEV-1845
Teva Pharmaceutical
migraines
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Therapeutics: And Now We Wait
Barron's
Fri, 06/10/16 - 04:13 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
After recent stock surge, Sarepta looks to raise $38M in offering
Bizjournals.com
Thu, 06/9/16 - 10:03 am
Sarepta Therapeutics
eteplirsen
stock offering
FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision
Bizjournals.com
Fri, 06/3/16 - 09:52 pm
FDA
Sarepta Therapeutics
Janet Woodcock
Duchenne Muscular Dystrophy
eteplirsen
Sarepta sinks as FDA changes drug approval rules
CNBC
Thu, 06/2/16 - 04:08 pm
Sarepta Therapeutics
FDA
drug approvals
eteplirsen
Duchenne Muscular Dystrophy
Why BioMarin’s Bad News is Great for Sarepta
Barron's
Wed, 06/1/16 - 09:43 pm
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Delayed FDA Decision Sends Sarepta Therapeutics Soaring
Yahoo/Market Realist
Fri, 05/27/16 - 12:47 pm
Sarepta Therapeutics
DMD
FDA
eteplirsen
Is the FDA’s decision to delay Sarepta drug decision good or bad? Nobody really knows
Marketwatch
Wed, 05/25/16 - 09:21 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Surges After U.S. Regulators Delay Ruling on DMD Drug
Bloomberg
Wed, 05/25/16 - 09:29 am
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Senators urge FDA to approve Sarepta drug for Duchenne
Stat
Tue, 05/24/16 - 11:12 am
Senate
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 End Of May FDA Decisions To Watch
Seeking Alpha
Mon, 05/23/16 - 07:03 pm
FDA
Sarepta Therapeutics
Titan Pharmaceuticals
Duchenne Muscular Dystrophy
eteplirsen
Probuphine
opioid addiction
Sarepta's AdCom Needs FDA's Permission To Speak Freely
Forbes
Mon, 05/16/16 - 11:55 am
Sarepta Therapeutics
FDA
eteplirsen
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
Fri, 05/13/16 - 10:08 am
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
What's Sarepta Therapeutics Inc.'s Next Move?
Motley Fool
Tue, 05/10/16 - 09:43 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta: The Path Forward
Seeking Alpha
Wed, 05/4/16 - 08:52 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Why it took so long for Sarepta to start a big trial of its Duchenne drug
Bizjournals.com
Tue, 05/3/16 - 05:15 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
clinical trials
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »